| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 08/22/2002 | WO2002064589A1 Laulimalide derivatives |
| 08/22/2002 | WO2002064586A2 Heterocyclic inhibitors of erk2 and uses thereof |
| 08/22/2002 | WO2002064584A1 Phthalayinone-piperidino-derivatives as pde4 inhibitors |
| 08/22/2002 | WO2002064580A1 Lactone compounds as novel photoinitiators |
| 08/22/2002 | WO2002064558A2 Oxazole derivatives, their preparation and their use as cytokine inhibitors |
| 08/22/2002 | WO2002064550A1 Glucocorticoid receptor modulators |
| 08/22/2002 | WO2002064161A2 Method and compositions for immunization with the pseudomonas v antigen |
| 08/22/2002 | WO2002064160A2 Pharmaceutical compositions which inhibit vascular proliferation and method of use thereof |
| 08/22/2002 | WO2002064153A1 Ixeris dendata extracting having biological activities and immune enhancing effects |
| 08/22/2002 | WO2002064138A1 Preparations and use of an ah receptor ligand, 2-(1'h-indole-3'-carbonyl)-thiazole-4-carboxylic acid methyl ester |
| 08/22/2002 | WO2002064131A2 Inflammation-inhibiting compounds |
| 08/22/2002 | WO2002064096A2 Methods of using pyrimidine-based antiviral agents |
| 08/22/2002 | WO2002064083A2 Synthesis of 3-amino-thalidomide and its enantiomers |
| 08/22/2002 | WO2002047534A3 Compositions and methods for the therapy and diagnosis of lung cancer |
| 08/22/2002 | WO2002040044A3 Chemoattractant recruitment of dendritic cells for enhancement of immunization |
| 08/22/2002 | WO2002032893A3 Piperidine compounds as anti-allergic |
| 08/22/2002 | WO2002032404A3 Nanoparticles |
| 08/22/2002 | WO2002002773A3 Dual specificity antibodies and methods of making and using |
| 08/22/2002 | WO2002000233A3 Purging of cells using viruses |
| 08/22/2002 | WO2001085204A3 Therapeutic method and composition utilizing antigen-antibody complexation and presentation by dendritic cells |
| 08/22/2002 | WO2001085203A3 Therapeutic method and composition utilizing antigen-antibody complexation and presentation by dendritic cells |
| 08/22/2002 | WO2001074903A3 Cd20/ige-receptor like molecules and uses thereof |
| 08/22/2002 | WO2001072295A3 Compositions and methods for the therapy and diagnosis of lung cancer |
| 08/22/2002 | WO2000038706A9 Methods for treating cancer and for mediating chemotaxis of dendritic cells |
| 08/22/2002 | WO2000036092A9 METHOD FOR THE HIGH LEVEL EXPRESSION OF ACTIVE LYMPHOTOXIN-β RECEPTOR IMMUNOGLOBULIN CHIMERIC PROTEINS AND THEIR PURIFICATION |
| 08/22/2002 | US20020115856 Selective cyclooxygenase-2 (COX-2) inhibitors; for example, 1-(5-Methanesulfonyl-pyridin-2-yl)-7-methoxy-3-trifluoromethyl-4,5-dihydro -1H-benzo(g)indazole |
| 08/22/2002 | US20020115825 Peptide for use in the treatment of gastrointestinal inflammation and defects of the blood brain barrier |
| 08/22/2002 | US20020115690 Free of alcohol and propylene glycol; surfactant; polyethylene glycol solvent having a mean molecular weight of greater than 300 but lower than 600 |
| 08/22/2002 | US20020115684 2, 7-naphthyridine derivatives |
| 08/22/2002 | US20020115666 N-phenethyl-2-aryl-2-(4-(oxy-or amino-carbonylamino)piperidin-1-yl)acetamide derivatives |
| 08/22/2002 | US20020115662 Delta-opioid or mu-opioid receptor modulators; useful analgesics, immunosuppressants, antiinflammatory agents, agents for the treatment of respiratory diseases. |
| 08/22/2002 | US20020115658 Aniline disulfide derivatives for treating allergic diseases |
| 08/22/2002 | US20020115656 Administering 2-(1-(3-(5-Acetyl-3-(4-chloro-phenyl)-4,5,6,7-tetrahydro-pyrazolo-(4,3 -c)pyridin-1-yl)-2-hydroxy-propyl)-piperidin-4-ylamino)-benzonitrile for inhibiting cathepsins; for treating atopic diseases |
| 08/22/2002 | US20020115205 Receptor protein for use in the treatment of cancer, infections, psoraisis, asthma, allergies, viral diseases, arteriosclerosis, gland, eye, autoimmune, nervous system and psychological disorders |
| 08/22/2002 | US20020115203 Proteins for use in the treatment infectious, cancers and autoimmune disease |
| 08/22/2002 | US20020115151 Human defensin polypeptide Def-X, genomic DNA and cDNA, composition containing them and applications to diagnosis and to therapeutic treatment |
| 08/22/2002 | US20020115140 Nucleotide sequences coding preferential polypeptide for use in treatment of immmunological defects |
| 08/22/2002 | US20020115138 Nucleotide sequences coding transport protein for use in treat ment of tumors |
| 08/22/2002 | US20020115090 Expression analysis of KIAA nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer |
| 08/22/2002 | US20020115061 Peptides for inducing cytotoxic t lymphocyte responses to hepatitis c viris |
| 08/22/2002 | US20020114852 Extract of nerium species, pharmaceutical composition thereof and methods for preparation thereof |
| 08/22/2002 | US20020114816 Autoreactive peptides from human glutamic acid-decarboxylase (gad) |
| 08/22/2002 | US20020114807 Administering drug comprising a substance that specifically recognizes extracellular domain of signal regulatory proteins and that inhibits functioning of pathologic myeloid cells |
| 08/22/2002 | US20020114801 Heparanase specific molecular probes and their use in research and medical applications |
| 08/22/2002 | US20020114793 Methods for inducing the differentiation of monocytes into functional dendritic cells and immunotherapeutic compositions including such dendritic cells |
| 08/22/2002 | US20020114781 Interleukin antagonists for suppressing autoimmune respone via reducing number of antigen-reactive lymphocytes; treatment of rheumatic diseases |
| 08/22/2002 | CA2438501A1 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof |
| 08/22/2002 | CA2438215A1 Putative human enzymes |
| 08/22/2002 | CA2437811A1 Human g-protein chemokine receptor (ccr5) hdgnr10 |
| 08/22/2002 | CA2437358A1 Agonists and antagonists of sphingosine-1-phosphate receptors |
| 08/22/2002 | CA2436195A1 Laulimalide derivatives |
| 08/22/2002 | CA2433843A1 Molecules for disease detection and treatment |
| 08/22/2002 | CA2431033A1 Crystallization of igf-1 |
| 08/21/2002 | EP1233059A1 Influenza viruses with enhanced transcriptional and replicational capacities |
| 08/21/2002 | EP1233022A1 Acellular pertussis vaccines and methods of preparation thereof |
| 08/21/2002 | EP1233013A1 Novel phenylalanine derivatives |
| 08/21/2002 | EP1232758A1 Polynucleotide formulated for improved intracellular transfer |
| 08/21/2002 | EP1232748A1 Substituted nitrobenzene derivatives as medicines and other useful uses thereof |
| 08/21/2002 | EP1232267A2 Activation of hcv-specific t cells |
| 08/21/2002 | EP1232264A2 Human fgf-21 gene and gene expression products |
| 08/21/2002 | EP1232263A2 Polypeptides and nucleic acids encoding same |
| 08/21/2002 | EP1232186A2 Antibody to human gastrointestinal epithelial tumor antigen related to alpha 6 beta 4 integrin |
| 08/21/2002 | EP1232180A1 Polypeptides derived from vitamin d nuclear receptor, and their uses in particular for screening vitamin d analogues |
| 08/21/2002 | EP1232179A1 15 human secreted proteins |
| 08/21/2002 | EP1232175A2 Method of forming a peptide-receptor complex with zsig33 and therapeutic use thereof |
| 08/21/2002 | EP1232158A1 Anti-inflammatory oxo derivatives and hydroxy derivatives of pyrrolizines, and their pharmaceutical use |
| 08/21/2002 | EP1232150A1 Urea derivatives as anti-inflammatory agents |
| 08/21/2002 | EP1232144A2 Novel il-8 receptor antagonists |
| 08/21/2002 | EP1232139A1 Nervonic acid derivatives, their preparation and use |
| 08/21/2002 | EP1231983A2 Treatment of subnormal bone mineral density |
| 08/21/2002 | EP1231982A2 Use of phthalazine derivatives |
| 08/21/2002 | EP1231948A1 A propellant free spray-on skin patch composition for improving wound healing and for drug administration |
| 08/21/2002 | EP1231937A2 Tr3-specific binding agents and methods for their use |
| 08/21/2002 | EP1231930A1 HUMAN IgM ANTIBODIES TO CHEMOKINE RECEPTORS |
| 08/21/2002 | EP1231928A2 Phytotherapeutic composition as well as working method for improving the condition and the immune system of a human or animal with this composition |
| 08/21/2002 | EP1231927A2 Nontoxic vernix compositions and method of producing |
| 08/21/2002 | EP1231924A2 Treatment of systemic lupus erythematosus (sle) with dehydroepiandrosterone |
| 08/21/2002 | EP1231920A1 Solutions containing epinastine |
| 08/21/2002 | EP1231913A2 Treatment of cyclooxygenase-2 mediated disorders using conjugated fatty acid compounds |
| 08/21/2002 | EP1231836A2 Human ex vivo immune system |
| 08/21/2002 | EP1041991A4 Method for inhibiting cyclooxygenase-2 and tumor necrosis factor alpha |
| 08/21/2002 | EP0956034B1 Pharmaceutical compositions for the treatment of transplant rejection, autoimmune or inflammatory conditions comprising cyclosporin a and 40-0-(2-hydroxyethyl)-rapamycin |
| 08/21/2002 | EP0675715B1 Cell differentiation induction with mevalonate and mevalonolactone derivatives |
| 08/21/2002 | EP0637203B1 Regulation of the immune system |
| 08/21/2002 | CN1365360A Puring derivatives inhibitors of tyrosine kinase SYK |
| 08/21/2002 | CN1364625A Medicine for curing lupus erythematosus |
| 08/21/2002 | CN1364469A Method for preparing fres rehmannia root preparation |
| 08/21/2002 | CN1089344C Inhibitor of stem cell proliferation and uses thereof |
| 08/21/2002 | CN1089239C Pyrimidine nucleotide precursors of treatment of animal inflammations and tissue damages |
| 08/20/2002 | US6437165 Useful for treating immune mediated diseases and conditions, such as bone marrow, organ and tissue transplant rejection. |
| 08/20/2002 | US6437146 Mesangial proliferative glomerulonephritis |
| 08/20/2002 | US6437124 Xanthine derivatives which inhibit expression of adhesion molecules on human umbilical vein endothelial cell (huvec) monolayers at very low concentrations |
| 08/20/2002 | US6436997 Endogenous nitric oxide synthesis under conditions of low oxygen tension |
| 08/20/2002 | US6436992 Use of fumaric acid derivatives |
| 08/20/2002 | US6436987 Crystalline forms of (3S-trans)-2-[3,4-dihydro-4-hydroxy-3-(phenylmethyl)-2H-1-benzopyran-7-yl]-4-(trifluoromethyl)-benzoic acid |
| 08/20/2002 | US6436967 Process for preparing prodrugs of benzenesulfonamide-containing cox-2 inhibitors |
| 08/20/2002 | US6436965 Inhibition of phosphodiesterase; 3-carbocyclic(alkyl)oxy-2-aryl(alkyl)aminocarbonyl-1-aryl(alkyl)indole or azaindole derivatives |
| 08/20/2002 | US6436958 Inhibition of t cell function and class ii antigen expression thereby inhibiting macrophage mediated antigen presentation, and/or inhibition of release of il-1, tnf cytokines, and other inflammatory mediators; 2-phenyl-3-aroylbenzothiophenes |
| 08/20/2002 | US6436947 Trans cyclopentanyl purine analogs useful as immunosuppressants |
| 08/20/2002 | US6436942 Enantiomers of 1[(4-chloro-phenyl) phenylmethyl]-4-[(4-methylphenyl) sulfony]piperazine |